Corcept Therapeutics, Inc. (CORT)
73.34
+0.72
(+0.99%)
USD |
NASDAQ |
Jun 08, 16:00
73.34
0.00 (0.00%)
After-Hours: 16:34
Corcept Therapeutics EPS Diluted (Quarterly) : -0.2988 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Abeona Therapeutics, Inc. | -0.3016 |
| Merck & Co., Inc. | -1.715 |
| Liquidia Corp. | 0.5228 |
| Indivior Pharmaceuticals, Inc. | 0.6899 |
| ANI Pharmaceuticals, Inc. | 1.276 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -31.20M |
| Revenue (Quarterly) | 164.90M |
| Total Expenses (Quarterly) | 196.10M |
| Enterprise Value | 7.466B |
| Gross Profit Margin (Quarterly) | 98.25% |
| Profit Margin (Quarterly) | -18.92% |
| Earnings Yield | 0.48% |
| Normalized Earnings Yield | 0.4773 |